Could a common diabetes pill prevent heart failure after a heart attack?

NCT ID NCT05764057

Recruiting now Disease control Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated Jun 11, 2026 · Updated 27 times

Summary

This study tests whether dapagliflozin, a drug already used for diabetes and heart failure, can help the heart heal better after a heart attack. About 450 adults who have had a heart attack and have weak heart pumping will receive either the drug or a placebo for 6 months. The goal is to see if the drug improves heart function and reduces harmful changes in heart structure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEFT VENTRICULAR DYSFUNCTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Cardiology AP-HP Hôpital européen Georges - Pompidou
RECRUITING

Paris, 75015, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

acute myocardial infarction left ventricular failure Non-ST Elevated Myocardial Infarction ST-elevation myocardial infarction Ventricular Dysfunction, Left

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMI LEFT VENTRICULAR DYSFUNCTION NSTEMI STEMI